Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Revitas Announces Gross-to-Net Conference for Pharmaceutical Manufacturers

Revitas,Inc.
Posted on: 28 Oct 16

Revitas, Inc., the leader in enterprise-class solutions for compliance, revenue, and contract management, along with Breakaway Technologies, Inc., has opened registration for Transforming the Gross-to-Net Process Through Automation, a half-day conference being held Nov. 15 from noon to 6 p.m. in Philadelphia. This event is being offered as a pre-conference session to the CBI GTN 2016 Summit being held Nov. 16-17 at the DoubleTree by Hilton.

Hosted at The Hub at Commerce Square, Transforming the Gross-to-Net Process Through Automation will explore how current trends in government contracting, biosimilars, and the increasingly complex spectrum of rebates are driving gross-to-net automation. Experts and industry leaders will share experiences and best practices on how implementing automated gross-to-net processes can optimize operational efficiency, improve forecasting and accrual management, enhance reporting accuracy, and ensure regulatory compliance.

“As contracts become more complex and pressures on pricing and margins rise, accurate and consistent gross-to-net analysis, forecasting, and reporting are becoming ever more paramount,” said Brian Madocks, President and CEO of Revitas. “Automating those processes enables pharmaceutical manufacturers to protect against revenue leakage and maintain audit compliance.”

Attendees of the Gross-to-Net Conference will discuss the state of the industry, receive demonstrations of automation software, and provide feedback directly to vendors on how to improve technologies.

“Automation holds the key for pharmaceutical manufacturers looking to improve their contracting strategies, particularly in the face of mounting industry pressures and more stringent regulations,” said Michael Grosberg, Director of Industry Solutions for Breakaway Technologies. “The Revitas and Breakaway Gross-to-Net Conference is a great opportunity for generic and branded pharmaceutical manufacturers to learn about best-in-class solutions and compare notes with like-minded peers on best practices in gross-to-net automation.”

The Revitas and Breakaway Technologies Gross-to-Net Conference is geared toward finance, contract management, managed markets, and pricing professionals at generic, branded, and specialty pharmaceutical manufacturers. Register today.

About Revitas, Inc.

Revitas is the leading provider of enterprise-class solutions for channel and contract management, on premise and in the cloud. Revitas solutions enable organizations to accelerate revenue through diverse, multi-level sales channels and attain maximum value from contracts. For over 25 years, Revitas has empowered companies in channel-intensive industries to achieve best-in-class performance and sustainable competitive advantage. For more information, please visit www.revitasinc.com.

About Breakaway Technologies, Inc.

Breakaway Technologies is a business performance management (BPM) firm specializing in custom analytic solutions for more than a decade. Breakaway builds processes and works with software to improve budgeting, planning, forecasting, and consolidation processes. We assess processes rapidly and thoroughly, and commit chief thought leaders with both technology and business analysis backgrounds to each project to ensure success.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005106/en/

Business Wire
www.businesswire.com

Last updated on: 28/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.